BUSINESS
Pfizer Transferring MA/Distribution Rights for 3 Off-Patent Brands to Teikoku Seiyaku
Pfizer is transferring marketing authorizations and distribution rights for three off-patent brands - Seltouch (felbinac), Diacort (diflorasone diacetate), and Napageln (felbinac) - to Teikoku Seiyaku, the two companies said on February 27. A Teikoku Seiyaku spokesperson said that the move…
To read the full story
BUSINESS
- Nipro’s Stemirac Clinches Full Approval in Japan
November 17, 2026
- Kyorin Bags Japan Rights to Acadia’s Rett Syndrome Drug
November 17, 2026
- Eisai, J&J, Takeda among Firms Rolling Out Newly Listed Medicines in Japan
November 16, 2026
- Fuji Poised to Hit 10 Billion Yen Biosimilar Sales Mark, Led by Eylea Follow-On
November 16, 2026
- Seikagaku Sees Over a Year Before US Refiling of Herniated Disk Drug
November 16, 2026
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…





